Home/Filings/4/0001562180-25-000375
4//SEC Filing

Paravasthu Mukund 4

Accession 0001562180-25-000375

CIK 0001645113other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:23 PM ET

Size

10.4 KB

Accession

0001562180-25-000375

Insider Transaction Report

Form 4
Period: 2025-01-11
Paravasthu Mukund
Chief Operating Officer
Transactions
  • Sale

    Ordinary Shares

    2025-01-11$26.81/sh2,160$57,90631,437 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $26.44 USD to $27.185 USD; the price reported above reflects the weighted average sale price.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0002039078

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:23 PM ET
Size
10.4 KB